PMD105 - EVALUATING THE COST-EFFECTIVENESS OF SCREENING FOR THE GENETIC RISK OF THROMBOSIS DURING THE RECOMMENDATION OF COMBINED HORMONAL CONTRACEPTION FOR FIRST-TIME USERS IN SWITZERLAND

Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1554
https://www.valueinhealthjournal.com/article/S1098-3015(18)34856-3/fulltext
Title : PMD105 - EVALUATING THE COST-EFFECTIVENESS OF SCREENING FOR THE GENETIC RISK OF THROMBOSIS DURING THE RECOMMENDATION OF COMBINED HORMONAL CONTRACEPTION FOR FIRST-TIME USERS IN SWITZERLAND
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34856-3&doi=10.1016/j.jval.2018.09.1554
First page :
Section Title :
Open access? : No
Section Order : 932
Categories :
Tags :
Regions :
ViH Article Tags :